Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 1:32 PM ISTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
Dr Reddys launches generic version of Tobi in US market Farhat Nasim26 Jun 2019 3:07 PM ISTThe product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
Dr Reddys unveils generic version of Vitamin K1 injection in US Medical Dialogues Bureau25 Jun 2019 10:52 AM ISTThe Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic, had combined US sales of approximately USD 46.6 million MAT for...
Dr Reddys yields positive results from phase 2b study of new psoriasis drug Farhat Nasim10 Jun 2019 2:02 PM ISTThe detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China Farhat Nasim3 Jun 2019 11:00 AM ISTDr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction Farhat Nasim28 March 2019 12:06 PM ISTDr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
USFDA completes audit for Dr Reddys Shreveport plant, no observations issued Medical Dialogues Bureau23 Feb 2019 9:30 AM IST"The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
Dr Reddy's Lab shares gain 3 percent on zero USFDA observations for Srikakulam plant Ruby Khatun Khatun5 Jun 2018 10:30 AM ISTNew Delhi: Shares of Dr Reddys Laboratories rose by nearly 3 percent after the company said the USFDA has completed its API Srikakulam plant audit...
DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns Medical Dialogues Bureau9 Feb 2018 11:28 AM ISTHYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
Dr Reddy's gets EIR for Hyderabad facility Ruby Khatun Khatun4 Dec 2017 10:45 AM ISTNew Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its...
Dr Reddy's gets nod to restart exports to EU from Vizag plant Ruby Khatun Khatun2 Dec 2017 10:30 AM ISTNew Delhi: Dr. Reddy's Laboratories said a German regulatory authority has allowed company's Visakhapatnam-based plant to restart production for the...
Securities class action lawsuit served on Dr Reddys in US Ruby Khatun Khatun1 Dec 2017 10:41 AM ISTNew Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
